Ashvattha
2. 11-50
bio & pharma
plum alley investments
tribe capital
Ashvattha Therapeutics creates products that selectively target and treat human diseases. Ashvattha enables precision targeting for therapeutics eliminating off-target toxicity, systemic side effects, and immunogenicity seen in other platforms. Ashvattha has a pipeline of nine therapeutics in neurology, oncology, and ophthalmology.
avttx.comRedwood City, CA, USA
Inaccurate data? Flag it here.Open jobs at Ashvattha